(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

Oct 01, 2015 7:30 AM - Oct 02, 2015 2:45 PM

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Imaging in Oncology Clinical Trials: Central Audit Methods for Site Interpretation

Participate in cross-functional discussions about current audit method options and discuss how to implement audit plans for site image.

Back to Agenda

Session 5: Financial Implications of the New Approach - Will There Be Net Savings?

Session Chair(s)

Susanta Sarkar

Susanta Sarkar

President, Cadenzamed LLC, United States

This session will feature experiences from CRO and pharma and discussions on

What it means financially if you do an audit versus a central read

  • Cost of reads vs overall costs

  • Cost of reading under compressed timelines

  • Cost of delay to market

    • The service provider perspective
    What it means for pharma companies

    Speaker(s)

    Elizabeth Dalton

    Elizabeth Dalton

    VP, Technical Solutions, Calyx, United States

    Richard Patt, MD

    Richard Patt, MD

    Principal, RadMD, United States

    Centralized Reads

    Panel Q&A

    Panel Q&A

    , United States

    Have an account?

    Be informed and stay engaged.

    Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.